PRFX 0.98 (-10.91%)
IL0011651580Drug ManufacturersDrug Manufacturers - Specialty & Generic

PainReform (PRFX) Stock Highlights

0.98 | -10.91%
2024-04-16 04:21:46
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The companys product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Statistics

Range Today
0.98 1.14
Volume Today 86.9K
Range 1 Year
0.42 26.41
Volume 1 Year 99.38M
Range 3 Year
0.34 26.41
Volume 3 Year 279.56M
Range 10 Year
0.34 26.41
Volume 10 Year 307.05M

Highlights

Market Capitalization 1.9M (micro)
Floating Shares 1.12M
Current Price 0.98
Price To Earnings -0.16
Price To Book 0.26
Earnings Per Share -7.14
Payout Ratio 0%

Performance

Latest -10.91%
1 Month -48.15%
3 Months -60.8%
6 Months -59.17%
1 Year +66.1%
3 Years -73.8%
5 Years -87.35%
10 Years -87.35%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.